Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.39 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | LCK | P06239 | 1/20 | 0.38 |
| ▸ | PPARD | Q03181 | 1/20 | 0.38 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.38 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.38 |
| ▸ | PTGER4 | P35408 | 8/20 | 0.37 |
| ▸ | PTGER3 | P43115 | 7/20 | 0.37 |
| ▸ | PTGER2 | P43116 | 6/20 | 0.37 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.36 |
| ▸ | THRB | P10828 | 1/20 | 0.35 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.34 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.34 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.34 |
| ▸ | GRIK2 | Q13002 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28636423 | 0.84 | THRB (0.48) | PTGER4PTGER3PTGER2THRB | |
| SCHEMBL30801444 | 0.79 | LCK (0.55) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL30023888 | 0.79 | LCK (0.55) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL16046797 | 0.79 | LCK (0.55) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL31607401 | 0.79 | LCK (0.55) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL1456490 | 0.79 | LCK (0.55) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL1457468 | 0.79 | LCK (0.55) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL8735257 | 0.76 | LCK (0.52) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL5375201 | 0.76 | LCK (0.52) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL1032475 | 0.76 | LCK (0.47) | GPR84FFAR1MAPTLCKPPARD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-5171180-A | — | — | None | — | — | JP | disclosed |
| EP-1498407-B1 | Method of producing acetate derivative | KAO CORP (JP) | 2012-09-05 | — | — | EP | disclosed |
| US-7078559-B2 | Method of producing acetate derivative | KAO CORPORATION (JP) | 2006-07-18 | — | — | US | disclosed |
| US-20050014968-A1 | Method of producing acetate derivative | KAO CORPORATION (JP) | 2005-01-20 | — | — | US | disclosed |
| EP-1498407-A1 | Method of producing acetate derivative | Kao Corporation (JP) | 2005-01-19 | — | — | EP | disclosed |
| EP-0685444-A1 | Aromatic compounds and their use in perfumery | FIRMENICH SA (CH) | 1995-12-06 | — | — | EP | disclosed |
| JP-H05171180-A | PERFUME COMPOSITION | KAO CORP | 1993-07-09 | — | — | JP | disclosed |
| US-4028278-A | Cycloaliphatic unsaturated ketones as fragrance modifying agents | FIRMENICH S.A. (CH) | 1977-06-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050014968-A1 | Method of producing acetate derivative | DECR1, CYP51A1, DECR2 | GPR84 1826/4885FFAR1 234/4885MAPT 4337/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.